{"id":"doxorubicin-ifosfamide-cisplatin","safety":{"commonSideEffects":[{"rate":"30-50%","effect":"Myelosuppression"},{"rate":"20-40%","effect":"Nausea and vomiting"},{"rate":"20-40%","effect":"Neutropenia"},{"rate":"10-30%","effect":"Anemia"},{"rate":"5-20%","effect":"Thrombocytopenia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Doxorubicin is an anthracycline antibiotic that intercalates DNA strands, inhibiting topoisomerase II and causing DNA damage. Ifosfamide is an alkylating agent that cross-links DNA, causing DNA damage and cell death. Cisplatin is a platinum-based alkylating agent that forms platinum-DNA adducts, inhibiting DNA replication and transcription.","oneSentence":"Doxorubicin, ifosfamide, and cisplatin work by interfering with DNA replication and function, leading to cell death in rapidly dividing cancer cells.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:09:58.145Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Metastatic urothelial carcinoma"},{"name":"Metastatic non-small cell lung cancer"},{"name":"Soft tissue sarcoma"}]},"trialDetails":[{"nctId":"NCT07477457","phase":"PHASE2","title":"A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2026-03-11","conditions":"Osteosarcoma, Metastasis","enrollment":45},{"nctId":"NCT04486391","phase":"PHASE3","title":"Tislelizumab Monotherapy Versus Salvage Chemotherapy for Relapsed/Refractory Classical Hodgkin Lymphoma","status":"TERMINATED","sponsor":"BeiGene","startDate":"2020-12-14","conditions":"Classical Hodgkin Lymphoma","enrollment":3},{"nctId":"NCT07321912","phase":"PHASE2","title":"Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma","status":"NOT_YET_RECRUITING","sponsor":"Milton S. Hershey Medical Center","startDate":"2026-04-01","conditions":"Osteosarcoma, Ewing Sarcoma, Ewing Sarcoma Metastatic","enrollment":406},{"nctId":"NCT03643133","phase":"PHASE2","title":"Mifamurtide Combined With Post-operative Chemotherapy for Newly Diagnosed High Risk Osteosarcoma Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"UNICANCER","startDate":"2018-10-23","conditions":"Osteosarcoma","enrollment":60},{"nctId":"NCT06520163","phase":"PHASE3","title":"Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma","status":"RECRUITING","sponsor":"The Affiliated People's Hospital of Ningbo University","startDate":"2024-08-01","conditions":"Non-Hodgkin's Lymphoma, Hematopoietic Stem Cell Mobilization","enrollment":99},{"nctId":"NCT06333314","phase":"PHASE2","title":"Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI","status":"RECRUITING","sponsor":"UNICANCER","startDate":"2024-07-23","conditions":"Pancreatic Adenocarcinoma, Ampulla of Vater Carcinoma, Adrenocortical Carcinoma","enrollment":120},{"nctId":"NCT07187960","phase":"PHASE3","title":"Evaluation of the Efficacy and Safety of TQB2825 Injection Compared to Immunotherapy in the Treatment of Recurrent/Refractory Follicular Lymphoma","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.","startDate":"2025-11","conditions":"Follicular Lymphoma","enrollment":228},{"nctId":"NCT07142863","phase":"PHASE2","title":"Envafolimab Combined With Neoadjuvant Chemotherapy Treat Stage IIb Resectable Osteosarcoma Patients","status":"NOT_YET_RECRUITING","sponsor":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2025-08-25","conditions":"Osteosarcoma, Neoadjuvant Therapy, Neoadjuvant Chemotherapy","enrollment":23},{"nctId":"NCT03034304","phase":"PHASE1","title":"A Phase I Clinical Study for Evaluating the Safety and Efficacy of MASCT-I in Patients With Advanced Solid Tumors","status":"TERMINATED","sponsor":"HRYZ Biotech Co.","startDate":"2017-02-22","conditions":"Advanced Solid Tumors","enrollment":105},{"nctId":"NCT04221035","phase":"PHASE3","title":"High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)","status":"RECRUITING","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","startDate":"2019-11-05","conditions":"High-Risk Neuroblastoma, Patient With Insufficient Response Chemoimmunotherapy","enrollment":800},{"nctId":"NCT00470223","phase":"PHASE3","title":"Combined Chemotherapy With or Without Zoledronic Acid for Patients With Osteosarcoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"UNICANCER","startDate":"2007-03","conditions":"Sarcoma","enrollment":318},{"nctId":"NCT04668365","phase":"PHASE2","title":"Zanubrutinib Combined With Standard Chemotherapy in the Treatment for Patients With Diffuse Large B Cell Lymphoma","status":"SUSPENDED","sponsor":"Henan Cancer Hospital","startDate":"2020-12-25","conditions":"Diffuse Large B Cell Lymphoma, CD79A Gene Mutation, CD79B Gene Mutation","enrollment":59},{"nctId":"NCT04701645","phase":"PHASE1","title":"Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer","status":"RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2022-11-01","conditions":"Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer","enrollment":20},{"nctId":"NCT03277924","phase":"PHASE1, PHASE2","title":"Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone Sarcomas","status":"COMPLETED","sponsor":"Grupo Espanol de Investigacion en Sarcomas","startDate":"2017-05-31","conditions":"Soft Tissue Sarcoma, Bone Sarcoma","enrollment":197},{"nctId":"NCT02348216","phase":"PHASE1, PHASE2","title":"Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgkin Lymphoma","status":"COMPLETED","sponsor":"Kite, A Gilead Company","startDate":"2015-04-21","conditions":"Refractory Diffuse Large B Cell Lymphoma (DLBCL), Relapsed Diffuse Large B-Cell Lymphoma, Transformed Follicular Lymphoma (TFL)","enrollment":307},{"nctId":"NCT01459484","phase":"PHASE2","title":"ABCB1/P-glycoprotein Expression as Biologic Stratification Factor for Patients With Non Metastatic Osteosarcoma","status":"COMPLETED","sponsor":"Italian Sarcoma Group","startDate":"2011-06-23","conditions":"Osteosarcoma","enrollment":225},{"nctId":"NCT05926492","phase":"PHASE2","title":"A Clinical Study of Surufatinib Combined With Chemotherapy as Neoadjuvant Treatment in Osteosarcoma","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2024-01-09","conditions":"Osteosarcoma","enrollment":160},{"nctId":"NCT06302465","phase":"NA","title":"Narlumosbartmab Combined With Neoadjuvant Chemotherapy in Bone-derived Malignancies With Osteolytic Lesions and Multinucleated Giant Cells","status":"RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2024-05-01","conditions":"Malignant Bone Tumor","enrollment":60},{"nctId":"NCT06263530","phase":"","title":"Prognostic Significance of ctDNA in HL","status":"RECRUITING","sponsor":"Interni hematologicka klinika FNKV","startDate":"2022-01-02","conditions":"Prognostic Cancer Model","enrollment":500},{"nctId":"NCT06204614","phase":"EARLY_PHASE1","title":"Drug Screening Using IMD in Bladder Cancer","status":"UNKNOWN","sponsor":"Brigham and Women's Hospital","startDate":"2024-02-14","conditions":"Muscle Invasive Bladder Urothelial Carcinoma","enrollment":18},{"nctId":"NCT00667342","phase":"PHASE2","title":"A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma","status":"COMPLETED","sponsor":"St. Jude Children's Research Hospital","startDate":"2008-06-03","conditions":"Osteosarcoma, Malignant Fibrous Histiocytoma (MFH) of Bone","enrollment":43},{"nctId":"NCT00134030","phase":"PHASE3","title":"Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2005-11-14","conditions":"Localized Osteosarcoma, Metastatic Osteosarcoma","enrollment":1334},{"nctId":"NCT02099175","phase":"PHASE2","title":"Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Operable Patients","status":"UNKNOWN","sponsor":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milano","startDate":"2013-11","conditions":"Sinonasal Tumors","enrollment":41},{"nctId":"NCT02099188","phase":"PHASE2","title":"Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Inoperable Patients","status":"UNKNOWN","sponsor":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milano","startDate":"2013-11","conditions":"Unresectable Sinonasal Tumors","enrollment":27},{"nctId":"NCT05244642","phase":"PHASE3","title":"A Phase III Study to Evaluate the Efficacy and Safety of Penpulimab in the Relapsed and Refractory Classical Hodgkin's Lymphoma","status":"RECRUITING","sponsor":"Akeso","startDate":"2022-02-15","conditions":"Hodgkin Disease Lymphoma","enrollment":60},{"nctId":"NCT04383288","phase":"","title":"ABCB1/P-glycoprotein Expression Influence on Non-metastatic Osteosarcoma of the Extremities","status":"COMPLETED","sponsor":"Grupo Espanol de Investigacion en Sarcomas","startDate":"2014-07-02","conditions":"Osteosarcoma","enrollment":115},{"nctId":"NCT00302003","phase":"PHASE3","title":"Combination Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Lymphoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2006-02","conditions":"Childhood Favorable Prognosis Hodgkin Lymphoma, Childhood Lymphocyte Depletion Hodgkin Lymphoma, Childhood Mixed Cellularity Hodgkin Lymphoma","enrollment":287},{"nctId":"NCT02788201","phase":"PHASE2","title":"Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2017-03-27","conditions":"Urothelial Carcinoma, Bladder Cancer, Urinary Bladder Neoplasms","enrollment":8},{"nctId":"NCT00003086","phase":"PHASE1, PHASE2","title":"Repeated Bone Marrow Transplantation in Treating Women With Advanced Breast Cancer","status":"TERMINATED","sponsor":"Louisiana State University Health Sciences Center Shreveport","startDate":"1997-03","conditions":"Breast Cancer","enrollment":12},{"nctId":"NCT04351308","phase":"PHASE2","title":"Comparison of MAPI+Camrelizumab Versus API+Apatinib Versus MAPI in Patients With a Poor Response to Preoperative Chemotherapy for Newly Diagnosed High-grade Osteosarcoma","status":"UNKNOWN","sponsor":"Peking University People's Hospital","startDate":"2020-05-01","conditions":"Osteosarcoma, Survival, Chemotherapy Effect","enrollment":60},{"nctId":"NCT00002565","phase":"PHASE3","title":"Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"1994-05-25","conditions":"Lymphoma","enrollment":61},{"nctId":"NCT01362530","phase":"PHASE3","title":"A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2011-09-13","conditions":"Chemotherapy Induced Nausea and Vomiting","enrollment":307},{"nctId":"NCT02784015","phase":"PHASE2","title":"Response Based Treatment for Children With Unresectable Localized Soft Tissue Sarcoma","status":"UNKNOWN","sponsor":"Samsung Medical Center","startDate":"2016-05","conditions":"Unresectable Localized Soft Tissue Sarcoma","enrollment":41},{"nctId":"NCT03360760","phase":"NA","title":"Timing of Surgery in Nonmetastatic Osteosarcoma of the Pelvis and Sacrum","status":"UNKNOWN","sponsor":"Peking University People's Hospital","startDate":"2018-08-01","conditions":"Osteosarcoma of Pelvis","enrollment":100},{"nctId":"NCT03390946","phase":"PHASE2","title":"Feasibility Study of Interval Compressed Regimen Using Four-drugs for Osteosarcoma","status":"UNKNOWN","sponsor":"Byung-Kiu Park","startDate":"2018-02-01","conditions":"Osteosarcoma, Feasibility, Treatment Response","enrollment":23},{"nctId":"NCT00002601","phase":"PHASE2","title":"Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Sarcoma","status":"COMPLETED","sponsor":"City of Hope Medical Center","startDate":"1994-09","conditions":"Sarcoma","enrollment":13},{"nctId":"NCT03042429","phase":"PHASE3","title":"Combination Chemotherapy Followed by Stem Cell Transplant in High-risk Neuroblastoma Patients","status":"COMPLETED","sponsor":"University of Cologne","startDate":"2007-01-01","conditions":"Neuroblastoma","enrollment":360},{"nctId":"NCT03034850","phase":"","title":"Thrombin Generation and Platelet Activation in CRS/HIPEC","status":"COMPLETED","sponsor":"Ziekenhuis Oost-Limburg","startDate":"2015-04","conditions":"Mesothelioma; Peritoneum, Pseudomyxoma Peritonei, Peritoneal Carcinomatosis","enrollment":27},{"nctId":"NCT02986503","phase":"","title":"European Study in Bone Sarcoma Patients Over 40 Years","status":"COMPLETED","sponsor":"Italian Sarcoma Group","startDate":"2002-01","conditions":"Spindle Cell Sarcoma of Bone, Osteosarcoma","enrollment":100},{"nctId":"NCT00920153","phase":"PHASE3","title":"Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin Lymphoma","status":"TERMINATED","sponsor":"French Innovative Leukemia Organisation","startDate":"2008-05","conditions":"Lymphoma","enrollment":442},{"nctId":"NCT00003852","phase":"PHASE2","title":"Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors","status":"TERMINATED","sponsor":"UNICANCER","startDate":"1998-03","conditions":"Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Ovarian Cancer","enrollment":45},{"nctId":"NCT02771743","phase":"PHASE2","title":"Response-based Treatment of High-risk Neuroblastoma","status":"UNKNOWN","sponsor":"Samsung Medical Center","startDate":"2015-04","conditions":"Newly Diagnosed High Risk Neuroblastoma","enrollment":54},{"nctId":"NCT00526318","phase":"NA","title":"Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma","status":"UNKNOWN","sponsor":"German Society for Pediatric Oncology and Hematology GPOH gGmbH","startDate":"2007-01","conditions":"Neuroblastoma","enrollment":360},{"nctId":"NCT00658580","phase":"PHASE3","title":"Randomized Study of Cisplatin-Etoposide Versus an Etoposide Regimen Without Cisplatin in Extensive Small-Cell Lung Cancer","status":"COMPLETED","sponsor":"European Lung Cancer Working Party","startDate":"2000-04","conditions":"Small Cell Lung Carcinoma, Extensive Disease","enrollment":361},{"nctId":"NCT00673179","phase":"NA","title":"Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy","status":"TERMINATED","sponsor":"M.D. Anderson Cancer Center","startDate":"2008-05","conditions":"Osteosarcoma","enrollment":7},{"nctId":"NCT00003937","phase":"PHASE3","title":"Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"1999-09","conditions":"Cardiac Toxicity, Sarcoma","enrollment":253},{"nctId":"NCT00742924","phase":"PHASE1","title":"Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2008-08","conditions":"Sarcoma","enrollment":24},{"nctId":"NCT00017368","phase":"PHASE2","title":"Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2001-04","conditions":"Neuroblastoma","enrollment":42},{"nctId":"NCT00002822","phase":"PHASE3","title":"Combination Chemotherapy Followed by Radiation Therapy in Patients With Small Cell Lung Cancer","status":"COMPLETED","sponsor":"Medical Research Council","startDate":"1996-03","conditions":"Lung Cancer","enrollment":400},{"nctId":"NCT00002802","phase":"PHASE3","title":"Therapy Based on Stage of Disease and Risk Assessment in Treating Children With Neuroblastoma","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"1990-07","conditions":"Neuroblastoma","enrollment":500},{"nctId":"NCT01258634","phase":"PHASE1","title":"A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response","status":"TERMINATED","sponsor":"University of Chicago","startDate":"2010-07","conditions":"Osteosarcoma, Lung Metastases","enrollment":2},{"nctId":"NCT00025064","phase":"PHASE2","title":"Combination Chemotherapy With or Without Radiation Therapy and Peripheral Stem Cell Transplant in Treating Children With Hodgkin's Lymphoma","status":"UNKNOWN","sponsor":"Children's Cancer and Leukaemia Group","startDate":"2000-01","conditions":"Lymphoma","enrollment":260},{"nctId":"NCT00410631","phase":"PHASE3","title":"Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma","status":"UNKNOWN","sponsor":"German Society for Pediatric Oncology and Hematology GPOH gGmbH","startDate":"2004-10","conditions":"Neuroblastoma","enrollment":642},{"nctId":"NCT00017225","phase":"PHASE2","title":"Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma","status":"COMPLETED","sponsor":"German Society for Pediatric Oncology and Hematology GPOH gGmbH","startDate":"1997-05","conditions":"Neuroblastoma","enrollment":""},{"nctId":"NCT00003105","phase":"PHASE1, PHASE2","title":"Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder Cancer","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"1997-09","conditions":"Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter","enrollment":30},{"nctId":"NCT00003776","phase":"PHASE2","title":"Combination Chemotherapy and Surgery in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"1998-12","conditions":"Sarcoma","enrollment":""},{"nctId":"NCT00023998","phase":"PHASE2","title":"Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2001-07","conditions":"Metastatic Osteosarcoma","enrollment":80},{"nctId":"NCT00080795","phase":"PHASE2","title":"Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2001-07","conditions":"Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer","enrollment":65},{"nctId":"NCT00002524","phase":"PHASE2","title":"Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"1993-06","conditions":"Lymphoma","enrollment":46},{"nctId":"NCT00267046","phase":"PHASE2","title":"Evaluate PKs and Efficacy Assessment of Palifermin in Patients With Sarcoma","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2005-12","conditions":"Sarcoma, Oral Mucositis","enrollment":49},{"nctId":"NCT00965172","phase":"PHASE2","title":"Caphosol in Sarcoma Patients With Mucositis","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2010-04","conditions":"Sarcoma, Oral Mucositis","enrollment":30},{"nctId":"NCT00691236","phase":"PHASE2, PHASE3","title":"Evaluation of Zoledronic Acid as a Single Agent or as an Adjuvant to Chemotherapy in High Grade Osteosarcoma","status":"UNKNOWN","sponsor":"Tata Memorial Hospital","startDate":"2008-05","conditions":"Osteosarcoma","enrollment":60},{"nctId":"NCT00645632","phase":"NA","title":"Combination Chemotherapy in Treating Patients Undergoing Surgery for Newly Diagnosed High-Grade Osteosarcoma","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"1990-11","conditions":"Sarcoma","enrollment":60},{"nctId":"NCT00652860","phase":"PHASE2","title":"Combination Chemotherapy, Radiation Therapy, and Sargramostim Before and After Surgery in Treating Patients With Soft Tissue Sarcoma That Can Be Removed By Surgery","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2001-08","conditions":"Metastatic Cancer, Sarcoma","enrollment":39},{"nctId":"NCT00165139","phase":"PHASE2","title":"Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Neuroblastoma and Sarcomas","status":"COMPLETED","sponsor":"Dana-Farber Cancer Institute","startDate":"1996-01","conditions":"Neuroblastoma, Ewings Sarcoma, Non-rhabdomyosarcoma Soft Tissue Sarcoma","enrollment":20},{"nctId":"NCT00970385","phase":"PHASE3","title":"Study About Treatment of Newly Diagnosed Non Cutaneous Peripheral T Cell Lymphoma","status":"COMPLETED","sponsor":"University Hospital, Grenoble","startDate":"1995-01","conditions":"Peripheral T Cell Lymphoma","enrollment":95},{"nctId":"NCT00186849","phase":"PHASE2","title":"Therapy for Children With Advanced Stage High Risk Neuroblastoma","status":"COMPLETED","sponsor":"St. Jude Children's Research Hospital","startDate":"1997-10","conditions":"Neuroblastoma","enrollment":30},{"nctId":"NCT00696735","phase":"PHASE3","title":"High-Dose Therapy Treatment in Patients With Follicular Lymphoma","status":"COMPLETED","sponsor":"French Innovative Leukemia Organisation","startDate":"1994-06","conditions":"Follicular Lymphoma","enrollment":172},{"nctId":"NCT00162721","phase":"PHASE3","title":"The Addition of Polychemotherapy to Adjuvant Radiotherapy in the Treatment of Non-Metastatic Uterine Sarcomas","status":"UNKNOWN","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","startDate":"2001-09","conditions":"Uterine Sarcoma","enrollment":270}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"doxorubicin, ifosfamide, cisplatin","genericName":"doxorubicin, ifosfamide, cisplatin","companyName":"Gustave Roussy, Cancer Campus, Grand Paris","companyId":"gustave-roussy-cancer-campus-grand-paris","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Doxorubicin, ifosfamide, and cisplatin work by interfering with DNA replication and function, leading to cell death in rapidly dividing cancer cells. Used for Metastatic urothelial carcinoma, Metastatic non-small cell lung cancer, Soft tissue sarcoma.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}